SOLID TUMORS (PHASE 1)
Clinical trials for SOLID TUMORS (PHASE 1) explained in plain language.
Never miss a new study
Get alerted when new SOLID TUMORS (PHASE 1) trials appear
Sign up with your email to follow new studies for SOLID TUMORS (PHASE 1), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Antibody-Drug conjugate enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study is testing a new drug called ADCE-B05 in 180 people with advanced solid tumors that have stopped responding to standard treatments. The drug is an antibody-drug conjugate, designed to deliver a cancer-killing agent directly to tumor cells. The main goals ar…
Matched conditions: SOLID TUMORS (PHASE 1)
Phase: PHASE1 • Sponsor: Adcendo ApS • Aim: Disease control
Last updated Jun 23, 2026 11:56 UTC
-
New pill targets hard-to-treat cancers with BRAF mutation
Disease control Recruiting nowThis early-phase study tests an experimental drug called HSK42360-Na in about 159 adults with advanced solid tumors that have a specific BRAF V600 gene change and have not responded to standard treatments. The main goals are to find a safe dose and check for side effects. Researc…
Matched conditions: SOLID TUMORS (PHASE 1)
Phase: PHASE1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 18, 2026 11:47 UTC